Divalproex Sodium Tablet, Delayed Release
Product Images NDC 70518-2357

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-2357). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Divalproex Sodium 500mg 70518 2357 01

This is a description of a medication called Divalproex Sodium, which is a 500mg Delayed-Release Tablet. There are 100 tablets in a bottle and it is only available with a prescription. The medication details include the brand name, the dosage, the manufacturer, the NDC number, the LOT number, and the source NDC. The package insert has guidance regarding its usage directions. The medication should be stored at a temperature between 20-26°C (63-77°F) with some flexibility if it's between 15-30°C (59-86°F) [See USP]. Additionally, the medication must be kept away from children. Lastly, it has been packaged by RemedyRepack Inc. in Indiana, PA.*

FDA Label Image

Divalproex Sodium 500mg 70518 2357 02

Divalproex Sodium is a delayed-release tablet with a strength of 500mg. It is prescribed by a doctor and its usage directions are provided in the package insert. The lot number and expiration date are required for tracking the medication. The drug should be stored at room temperature and away from the reach of children. The medication was repackaged by RemedyRepack Inc. in Indiana. The National Drug Code (NDC) for the original manufacturer is 57237-0048-05, and the NDC for this package is 70518-2357-02.*

FDA Label Image

Divalproex Sodium 500mg 70518 2357 03

Divalproex Sodium is a delayed-release tablet that comes in the strength of 500mg. The pack size is 100 tablets, and it is available by prescription only. The NDC number is 70518-2357-03, and the manufacturing source NDC is 57237-0048-01. The manufacturer is Rising Pharma, Inc., located at Allendale, NJ 0740. The medication needs to be kept out of the reach of children, and the package insert must be followed for use. The lot number and expiry date are not available. The medication needs to be stored between 20-26°C (63-77°F). The RemedyRepack Inc., located at Indiana, PA 15701, has repackaged the medication.*

FDA Label Image

Divalproex Sodium 500mg 70518 2357 04

Divalproex Sodium Delayed-Release is a prescription medication in tablet form with a strength of 500mg. Its packaging and labeling includes the prescription drug name, dosage, and manufacturer details. It should be kept out of reach of children and stored under regulated temperature conditions. Directions for use are also available in the package insert. The medicine was repackaged by RemedyRepack Inc. in Indiana, PA.*

FDA Label Image

Remedy_label (Remedy Label)

This is a bottle of Divalproex Sodium Delayed-Release tablets containing 500mg each. The bottle has a quantity of 30 tablets and the NDC number is 70518-2357-00. The manufacturer is Rising Pharma, Inc. and it was repackaged by RemedyRepack Inc. The directions for use are on the package insert and it should be stored at 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F) [See USP]. It is Rx-only and should be kept out of the reach of children. The lot number and expiry date are not available.*

FDA Label Image

Figure 1 (Divalproex Fig1)

FDA Label Image

Figure 2 (Divalproex Fig2)

FDA Label Image

Figure 3 (Divalproex Fig3)

This is a chart titled "Reduction In CPS Rate" showing two lines labeled "High Dose" and "Low Dose" with an x-axis labeled "% of Patients" and a y-axis labeled "Improvement" with a scale from -50 to 50. The lines track the percentage of patients experiencing improvement, no change, or worsening over the course of treatment.*

FDA Label Image

Figure 4 (Divalproex Fig4)

The text provides a figure showing mean 4-week migraine rates for two studies comparing placebo and Divalproex Sodium delayed-release tablets. It also gives information about the mean dose of Divalproex Sodium delayed-release tablets used in one of the studies and the range of doses used in the other study.*

FDA Label Image

Chemical Structure (Divalproex Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.